Share Price and Basic Stock Data
Last Updated: December 18, 2025, 10:23 pm
| PEG Ratio | 11.99 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Clean Science & Technology Ltd operates within the specialty chemicals sector, showcasing its capabilities in producing advanced chemical solutions. Over the past few years, the company has demonstrated a robust trajectory in its revenue growth. For instance, sales surged from ₹241 Cr in FY 2018 to ₹936 Cr in FY 2023, reflecting a compound annual growth rate (CAGR) of approximately 60%. However, the latest fiscal year saw a slight dip with revenues recorded at ₹791 Cr for FY 2024, before bouncing back to ₹967 Cr in FY 2025. This volatility in sales raises questions about market demand fluctuations and operational efficiencies. The TTM revenue stands at ₹986 Cr, indicating a recovery trend that investors will likely monitor closely as the company seeks to stabilize its growth amidst changing market dynamics.
Profitability and Efficiency Metrics
When evaluating profitability metrics, Clean Science & Technology has maintained impressive operating margins, with an operating profit margin (OPM) that stood at 40% in FY 2025. This is a testament to the company’s effective cost management strategies, especially given that operating profit was recorded at ₹388 Cr for the same period. However, net profit margins have shown some fluctuation, declining from 31.54% in FY 2023 to 27.35% in FY 2025. Despite this, the return on equity (ROE) is commendable at 20.2%, reflecting strong shareholder value generation. Efficiency ratios, such as the cash conversion cycle (CCC), which stands at 129 days, suggest areas for improvement in working capital management. A shorter CCC would enhance liquidity and operational efficiency, allowing for a more agile response to market demands.
Balance Sheet Strength and Financial Ratios
The balance sheet of Clean Science & Technology appears robust, with total reserves rising to ₹1,489 Cr as of September 2025, showcasing prudent financial management. The company’s borrowings are minimal, reported at just ₹2 Cr, which positions it favorably against its liabilities. This low leverage is bolstered by an impressive interest coverage ratio (ICR) of 1024.52x, indicating that the company can comfortably meet its interest obligations. Furthermore, the price-to-book value (P/BV) ratio stands at 8.76x, hinting at a premium valuation compared to its book value of ₹133.28 per share. While a high P/BV can suggest overvaluation, it may also reflect investor confidence in the company’s growth potential. However, the declining return on capital employed (ROCE), which stood at 27% for FY 2025, raises concerns about how effectively the company is utilizing its capital to generate profits.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Clean Science & Technology reveals a significant shift in promoter holdings, which decreased from 78.5% in December 2022 to 50.96% by September 2025. This decline might raise eyebrows among investors, as it could indicate a dilution of control or a strategic move to attract institutional investors. Indeed, foreign institutional investors (FIIs) have increased their stake to 11.14%, while domestic institutional investors (DIIs) hold 18.97%. The public’s participation stands at 18.91%, which reflects a healthy interest from retail investors. The total number of shareholders has seen fluctuations, peaking at 2,85,259 in September 2023, before settling at 2,39,974. This dynamic could signal changing investor sentiments, potentially influenced by the company’s performance and market conditions.
Outlook, Risks, and Final Insight
Looking ahead, Clean Science & Technology faces a blend of opportunities and challenges. The company’s strong fundamentals suggest potential for continued growth, especially given its innovative product offerings in the specialty chemicals sector. However, the recorded volatility in sales and profits raises concerns about market stability and operational efficiency. Investors should be wary of risks related to fluctuations in raw material costs and competition in the specialty chemicals market, which could impact margins. Additionally, the shift in shareholding dynamics may create uncertainty regarding management strategies. Overall, while the company appears well-positioned with strong financial metrics, the evolving market landscape and internal dynamics necessitate careful monitoring. Investors would do well to weigh these factors against their risk appetite as they consider their positions in Clean Science & Technology.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 382 Cr. | 41.6 | 83.5/41.2 | 23.7 | 20.5 | 0.96 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 30.2 Cr. | 61.5 | 94.0/56.0 | 14.4 | 89.6 | 1.63 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.6 Cr. | 729 | 956/600 | 22.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,401 Cr. | 75.0 | 111/74.2 | 22.5 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 634 Cr. | 254 | 416/241 | 22.8 | 93.8 | 0.98 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,682.64 Cr | 717.55 | 69.91 | 183.02 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 234 | 248 | 237 | 217 | 188 | 181 | 195 | 228 | 224 | 238 | 241 | 264 | 243 |
| Expenses | 143 | 150 | 129 | 112 | 112 | 106 | 108 | 133 | 129 | 148 | 142 | 159 | 143 |
| Operating Profit | 91 | 97 | 108 | 105 | 76 | 75 | 87 | 95 | 95 | 90 | 98 | 105 | 100 |
| OPM % | 39% | 39% | 46% | 48% | 40% | 41% | 44% | 42% | 42% | 38% | 41% | 40% | 41% |
| Other Income | 2 | 3 | 13 | 13 | 13 | 6 | 8 | 14 | 10 | 11 | 5 | 12 | 13 |
| Interest | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 8 | 9 | 9 | 10 | 11 | 11 | 11 | 13 | 16 | 18 | 18 | 17 | 19 |
| Profit before tax | 85 | 92 | 112 | 108 | 79 | 69 | 83 | 95 | 89 | 83 | 85 | 100 | 95 |
| Tax % | 26% | 26% | 25% | 25% | 25% | 25% | 25% | 26% | 26% | 29% | 23% | 26% | 26% |
| Net Profit | 63 | 68 | 84 | 81 | 59 | 52 | 63 | 70 | 66 | 59 | 66 | 74 | 70 |
| EPS in Rs | 5.92 | 6.40 | 7.89 | 7.58 | 5.55 | 4.91 | 5.89 | 6.61 | 6.20 | 5.53 | 6.18 | 6.97 | 6.59 |
Last Updated: August 20, 2025, 2:35 am
Below is a detailed analysis of the quarterly data for Clean Science & Technology Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 243.00 Cr.. The value appears to be declining and may need further review. It has decreased from 264.00 Cr. (Mar 2025) to 243.00 Cr., marking a decrease of 21.00 Cr..
- For Expenses, as of Jun 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 159.00 Cr. (Mar 2025) to 143.00 Cr., marking a decrease of 16.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 100.00 Cr.. The value appears to be declining and may need further review. It has decreased from 105.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 5.00 Cr..
- For OPM %, as of Jun 2025, the value is 41.00%. The value appears strong and on an upward trend. It has increased from 40.00% (Mar 2025) to 41.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 95.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 95.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 70.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 6.59. The value appears to be declining and may need further review. It has decreased from 6.97 (Mar 2025) to 6.59, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:32 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 393 | 419 | 512 | 685 | 936 | 791 | 967 | 992 |
| Expenses | 167 | 257 | 234 | 253 | 385 | 533 | 459 | 579 | 602 |
| Operating Profit | 74 | 137 | 186 | 260 | 300 | 403 | 332 | 388 | 390 |
| OPM % | 31% | 35% | 44% | 51% | 44% | 43% | 42% | 40% | 39% |
| Other Income | 5 | 11 | 11 | 25 | 30 | 30 | 41 | 39 | 38 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 8 | 11 | 14 | 17 | 25 | 36 | 46 | 69 | 73 |
| Profit before tax | 70 | 137 | 182 | 267 | 305 | 396 | 326 | 357 | 354 |
| Tax % | 30% | 28% | 23% | 26% | 25% | 25% | 25% | 26% | |
| Net Profit | 49 | 98 | 140 | 198 | 228 | 295 | 244 | 264 | 265 |
| EPS in Rs | 345.41 | 689.84 | 1,051.67 | 18.68 | 21.51 | 27.78 | 22.97 | 24.88 | 24.96 |
| Dividend Payout % | 12% | 15% | 2% | 134% | 15% | 18% | 22% | 24% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 42.86% | 41.43% | 15.15% | 29.39% | -17.29% | 8.20% |
| Change in YoY Net Profit Growth (%) | 0.00% | -57.14% | -1.43% | -26.28% | 14.23% | -46.67% | 25.48% |
Clean Science & Technology Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 12% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 5% |
| TTM: | 7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -14% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 28% |
| 3 Years: | 24% |
| Last Year: | 20% |
Last Updated: September 5, 2025, 1:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:05 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 186 | 271 | 341 | 529 | 758 | 999 | 1,193 | 1,406 | 1,489 |
| Borrowings | 1 | 3 | 3 | 0 | 0 | 2 | 2 | 2 | 2 |
| Other Liabilities | 48 | 53 | 85 | 120 | 156 | 140 | 191 | 181 | 182 |
| Total Liabilities | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 | 1,684 |
| Fixed Assets | 102 | 127 | 166 | 186 | 296 | 460 | 636 | 715 | 689 |
| CWIP | 2 | 4 | 3 | 55 | 44 | 20 | 57 | 30 | 98 |
| Investments | 18 | 75 | 133 | 232 | 191 | 353 | 339 | 381 | 432 |
| Other Assets | 114 | 121 | 128 | 187 | 394 | 318 | 364 | 474 | 466 |
| Total Assets | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,396 | 1,600 | 1,684 |
Below is a detailed analysis of the balance sheet data for Clean Science & Technology Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,489.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,406.00 Cr. (Mar 2025) to 1,489.00 Cr., marking an increase of 83.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 182.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 181.00 Cr. (Mar 2025) to 182.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,684.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,600.00 Cr. (Mar 2025) to 1,684.00 Cr., marking an increase of 84.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 689.00 Cr.. The value appears to be declining and may need further review. It has decreased from 715.00 Cr. (Mar 2025) to 689.00 Cr., marking a decrease of 26.00 Cr..
- For CWIP, as of Sep 2025, the value is 98.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 98.00 Cr., marking an increase of 68.00 Cr..
- For Investments, as of Sep 2025, the value is 432.00 Cr.. The value appears strong and on an upward trend. It has increased from 381.00 Cr. (Mar 2025) to 432.00 Cr., marking an increase of 51.00 Cr..
- For Other Assets, as of Sep 2025, the value is 466.00 Cr.. The value appears to be declining and may need further review. It has decreased from 474.00 Cr. (Mar 2025) to 466.00 Cr., marking a decrease of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,684.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,600.00 Cr. (Mar 2025) to 1,684.00 Cr., marking an increase of 84.00 Cr..
Notably, the Reserves (1,489.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 73.00 | 134.00 | 183.00 | 260.00 | 300.00 | 401.00 | 330.00 | 386.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 55 | 61 | 53 | 82 | 57 | 76 | 77 |
| Inventory Days | 93 | 79 | 98 | 156 | 143 | 122 | 163 | 156 |
| Days Payable | 85 | 48 | 101 | 180 | 166 | 90 | 139 | 103 |
| Cash Conversion Cycle | 69 | 87 | 58 | 29 | 59 | 89 | 99 | 129 |
| Working Capital Days | 60 | 62 | 33 | 32 | 90 | 68 | 86 | 105 |
| ROCE % | 59% | 59% | 61% | 47% | 44% | 29% | 27% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 3,039,656 | 0.4 | 277.67 | 2,689,656 | 2025-12-15 03:04:08 | 13.01% |
| SBI Small Cap Fund | 2,190,596 | 0.55 | 200.11 | N/A | N/A | N/A |
| UTI Flexi Cap Fund | 1,577,000 | 0.56 | 144.06 | 1,520,000 | 2025-12-14 09:17:31 | 3.75% |
| Nippon India Multi Cap Fund | 1,409,193 | 0.26 | 128.73 | 862,926 | 2025-12-15 04:02:53 | 63.3% |
| SBI MNC Fund | 1,000,000 | 1.52 | 91.35 | N/A | N/A | N/A |
| Axis ELSS Tax Saver Fund | 747,849 | 0.19 | 68.32 | 878,470 | 2025-11-03 09:12:52 | -14.87% |
| Edelweiss Small Cap Fund | 614,757 | 1.05 | 56.16 | N/A | N/A | N/A |
| JM Flexicap Fund | 385,000 | 0.58 | 35.17 | 410,000 | 2025-12-14 03:26:00 | -6.1% |
| UTI Small Cap Fund | 356,238 | 0.67 | 32.54 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 343,636 | 0.17 | 31.39 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 24.88 | 22.97 | 27.79 | 21.51 | 18.68 |
| Diluted EPS (Rs.) | 24.88 | 22.96 | 27.78 | 21.51 | 18.68 |
| Cash EPS (Rs.) | 31.38 | 27.29 | 31.18 | 23.86 | 20.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 133.28 | 113.24 | 95.07 | 72.34 | 50.81 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 133.28 | 113.24 | 95.07 | 72.34 | 50.81 |
| Revenue From Operations / Share (Rs.) | 90.96 | 74.49 | 88.08 | 64.48 | 48.24 |
| PBDIT / Share (Rs.) | 40.11 | 35.14 | 40.66 | 31.05 | 26.79 |
| PBIT / Share (Rs.) | 33.61 | 30.82 | 37.26 | 28.71 | 25.17 |
| PBT / Share (Rs.) | 33.57 | 30.73 | 37.24 | 28.69 | 25.16 |
| Net Profit / Share (Rs.) | 24.88 | 22.97 | 27.78 | 21.51 | 18.68 |
| NP After MI And SOA / Share (Rs.) | 24.88 | 22.97 | 27.78 | 21.51 | 18.68 |
| PBDIT Margin (%) | 44.09 | 47.17 | 46.15 | 48.16 | 55.53 |
| PBIT Margin (%) | 36.94 | 41.36 | 42.29 | 44.52 | 52.18 |
| PBT Margin (%) | 36.90 | 41.25 | 42.27 | 44.50 | 52.16 |
| Net Profit Margin (%) | 27.35 | 30.83 | 31.54 | 33.36 | 38.71 |
| NP After MI And SOA Margin (%) | 27.35 | 30.83 | 31.54 | 33.36 | 38.71 |
| Return on Networth / Equity (%) | 18.66 | 20.28 | 29.22 | 29.73 | 36.75 |
| Return on Capital Employeed (%) | 24.59 | 26.48 | 38.19 | 38.61 | 47.92 |
| Return On Assets (%) | 16.44 | 17.47 | 25.62 | 24.71 | 30.06 |
| Asset Turnover Ratio (%) | 0.64 | 0.62 | 0.89 | 0.86 | 0.94 |
| Current Ratio (X) | 5.14 | 4.12 | 5.46 | 4.23 | 3.87 |
| Quick Ratio (X) | 4.18 | 3.35 | 4.51 | 3.57 | 3.36 |
| Inventory Turnover Ratio (X) | 7.08 | 2.43 | 3.44 | 3.48 | 3.15 |
| Dividend Payout Ratio (NP) (%) | 20.09 | 21.76 | 18.89 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.93 | 18.32 | 16.83 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 79.91 | 78.24 | 81.11 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.07 | 81.68 | 83.17 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 1024.52 | 403.19 | 2214.97 | 2243.95 | 3127.44 |
| Interest Coverage Ratio (Post Tax) (X) | 636.59 | 264.53 | 1514.72 | 1555.39 | 2181.00 |
| Enterprise Value (Cr.) | 12383.61 | 14100.43 | 13420.03 | 21095.82 | 0.00 |
| EV / Net Operating Revenue (X) | 12.81 | 17.82 | 14.34 | 30.80 | 0.00 |
| EV / EBITDA (X) | 29.06 | 37.77 | 31.07 | 63.95 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 12.83 | 17.83 | 14.35 | 30.91 | 0.00 |
| Retention Ratios (%) | 79.90 | 78.23 | 81.10 | 0.00 | 0.00 |
| Price / BV (X) | 8.76 | 11.73 | 13.30 | 27.55 | 0.00 |
| Price / Net Operating Revenue (X) | 12.83 | 17.83 | 14.35 | 30.91 | 0.00 |
| EarningsYield | 0.02 | 0.01 | 0.02 | 0.01 | 0.00 |
After reviewing the key financial ratios for Clean Science & Technology Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.96 (Mar 24) to 24.88, marking an increase of 1.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 31.38. This value is within the healthy range. It has increased from 27.29 (Mar 24) to 31.38, marking an increase of 4.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 133.28. It has increased from 113.24 (Mar 24) to 133.28, marking an increase of 20.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 133.28. It has increased from 113.24 (Mar 24) to 133.28, marking an increase of 20.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 90.96. It has increased from 74.49 (Mar 24) to 90.96, marking an increase of 16.47.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 40.11. This value is within the healthy range. It has increased from 35.14 (Mar 24) to 40.11, marking an increase of 4.97.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.61. This value is within the healthy range. It has increased from 30.82 (Mar 24) to 33.61, marking an increase of 2.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 33.57. This value is within the healthy range. It has increased from 30.73 (Mar 24) to 33.57, marking an increase of 2.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.88. This value is within the healthy range. It has increased from 22.97 (Mar 24) to 24.88, marking an increase of 1.91.
- For PBDIT Margin (%), as of Mar 25, the value is 44.09. This value is within the healthy range. It has decreased from 47.17 (Mar 24) to 44.09, marking a decrease of 3.08.
- For PBIT Margin (%), as of Mar 25, the value is 36.94. This value exceeds the healthy maximum of 20. It has decreased from 41.36 (Mar 24) to 36.94, marking a decrease of 4.42.
- For PBT Margin (%), as of Mar 25, the value is 36.90. This value is within the healthy range. It has decreased from 41.25 (Mar 24) to 36.90, marking a decrease of 4.35.
- For Net Profit Margin (%), as of Mar 25, the value is 27.35. This value exceeds the healthy maximum of 10. It has decreased from 30.83 (Mar 24) to 27.35, marking a decrease of 3.48.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 27.35. This value exceeds the healthy maximum of 20. It has decreased from 30.83 (Mar 24) to 27.35, marking a decrease of 3.48.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.66. This value is within the healthy range. It has decreased from 20.28 (Mar 24) to 18.66, marking a decrease of 1.62.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.59. This value is within the healthy range. It has decreased from 26.48 (Mar 24) to 24.59, marking a decrease of 1.89.
- For Return On Assets (%), as of Mar 25, the value is 16.44. This value is within the healthy range. It has decreased from 17.47 (Mar 24) to 16.44, marking a decrease of 1.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has increased from 0.62 (Mar 24) to 0.64, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 5.14. This value exceeds the healthy maximum of 3. It has increased from 4.12 (Mar 24) to 5.14, marking an increase of 1.02.
- For Quick Ratio (X), as of Mar 25, the value is 4.18. This value exceeds the healthy maximum of 2. It has increased from 3.35 (Mar 24) to 4.18, marking an increase of 0.83.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.08. This value is within the healthy range. It has increased from 2.43 (Mar 24) to 7.08, marking an increase of 4.65.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.09. This value is within the healthy range. It has decreased from 21.76 (Mar 24) to 20.09, marking a decrease of 1.67.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.93. This value is below the healthy minimum of 20. It has decreased from 18.32 (Mar 24) to 15.93, marking a decrease of 2.39.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.91. This value exceeds the healthy maximum of 70. It has increased from 78.24 (Mar 24) to 79.91, marking an increase of 1.67.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.07. This value exceeds the healthy maximum of 70. It has increased from 81.68 (Mar 24) to 84.07, marking an increase of 2.39.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1,024.52. This value is within the healthy range. It has increased from 403.19 (Mar 24) to 1,024.52, marking an increase of 621.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 636.59. This value is within the healthy range. It has increased from 264.53 (Mar 24) to 636.59, marking an increase of 372.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 12,383.61. It has decreased from 14,100.43 (Mar 24) to 12,383.61, marking a decrease of 1,716.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 12.81. This value exceeds the healthy maximum of 3. It has decreased from 17.82 (Mar 24) to 12.81, marking a decrease of 5.01.
- For EV / EBITDA (X), as of Mar 25, the value is 29.06. This value exceeds the healthy maximum of 15. It has decreased from 37.77 (Mar 24) to 29.06, marking a decrease of 8.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 12.83, marking a decrease of 5.00.
- For Retention Ratios (%), as of Mar 25, the value is 79.90. This value exceeds the healthy maximum of 70. It has increased from 78.23 (Mar 24) to 79.90, marking an increase of 1.67.
- For Price / BV (X), as of Mar 25, the value is 8.76. This value exceeds the healthy maximum of 3. It has decreased from 11.73 (Mar 24) to 8.76, marking a decrease of 2.97.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 12.83. This value exceeds the healthy maximum of 3. It has decreased from 17.83 (Mar 24) to 12.83, marking a decrease of 5.00.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Clean Science & Technology Ltd:
- Net Profit Margin: 27.35%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.59% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.66% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 636.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36.2 (Industry average Stock P/E: 69.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 27.35%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Office No. 603 & 604, 6th Floor, Tower No. 15, Cybercity, Pune Maharashtra 411013 | compliance@cleanscience.co.in http://www.cleanscience.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradeep Rathi | Chairman & Non-Exe.Director |
| Mr. Ashok Boob | Managing Director |
| Mr. Siddhartha Sikchi | Executive Director |
| Mr. Krishnakumar Boob | Executive Director |
| Mr. Parth Maheshwari | Executive Director |
| Mr. Sanjay Kothari | Non Executive Director |
| Mr. Keval Doshi | Ind. Non-Executive Director |
| Ms. Madhu Dubhashi | Ind. Non-Executive Director |
| Prof. Ganapati Yadav | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Clean Science & Technology Ltd?
Clean Science & Technology Ltd's intrinsic value (as of 19 December 2025) is 830.28 which is 8.15% lower the current market price of 904.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 9,602 Cr. market cap, FY2025-2026 high/low of 1,600/874, reserves of ₹1,489 Cr, and liabilities of 1,684 Cr.
What is the Market Cap of Clean Science & Technology Ltd?
The Market Cap of Clean Science & Technology Ltd is 9,602 Cr..
What is the current Stock Price of Clean Science & Technology Ltd as on 19 December 2025?
The current stock price of Clean Science & Technology Ltd as on 19 December 2025 is 904.
What is the High / Low of Clean Science & Technology Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Clean Science & Technology Ltd stocks is 1,600/874.
What is the Stock P/E of Clean Science & Technology Ltd?
The Stock P/E of Clean Science & Technology Ltd is 36.2.
What is the Book Value of Clean Science & Technology Ltd?
The Book Value of Clean Science & Technology Ltd is 141.
What is the Dividend Yield of Clean Science & Technology Ltd?
The Dividend Yield of Clean Science & Technology Ltd is 0.66 %.
What is the ROCE of Clean Science & Technology Ltd?
The ROCE of Clean Science & Technology Ltd is 27.3 %.
What is the ROE of Clean Science & Technology Ltd?
The ROE of Clean Science & Technology Ltd is 20.2 %.
What is the Face Value of Clean Science & Technology Ltd?
The Face Value of Clean Science & Technology Ltd is 1.00.